Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126086091 | 12608609 | 1 | I | 2014 | 20160725 | 20160729 | 20160729 | EXP | US-PFIZER INC-2016360632 | PFIZER | 60.00 | YR | F | Y | 73.00000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126086091 | 12608609 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, DAILY, ONE TABLET | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | |||||||
| 126086091 | 12608609 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100MG DAILY (50MG, TWO CAPSULES) | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | |||||||
| 126086091 | 12608609 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 12.5 MG, DAILY | 0 | 12.5 | MG | CAPSULE | |||||||
| 126086091 | 12608609 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.25MG ONE HALF TO ONE TABLET 3X/DAY AS NEEDED | 0 | TABLET | |||||||||
| 126086091 | 12608609 | 5 | C | FISH OIL | FISH OIL | 1 | Oral | 1200 MG, DAILY, TWO SOFT GELS | 0 | 1200 | MG | CAPSULE, SOFT | |||||||
| 126086091 | 12608609 | 6 | C | OMEGA 3 /01334101/ | OMEGA-3 FATTY ACIDS | 1 | Oral | 360 MG, DAILY, TWO SOFT GELS | 0 | 360 | MG | CAPSULE, SOFT | |||||||
| 126086091 | 12608609 | 7 | C | CALCIUM PLUS D3 | 2 | Oral | 2400 MG, DAILY, 1200MG TWO CAPSULES | 0 | 2400 | MG | CAPSULE | ||||||||
| 126086091 | 12608609 | 8 | C | CINNAMON. | CINNAMON | 1 | Oral | 1000 MG, DAILY, 500MG TWO CAPSULES | 0 | 1000 | MG | CAPSULE | |||||||
| 126086091 | 12608609 | 9 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | Oral | 200 MG, DAILY, ONE TABLET | 0 | 200 | MG | TABLET | |||||||
| 126086091 | 12608609 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 UG, DAILY, ONE TABLET | 0 | 1000 | UG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126086091 | 12608609 | 1 | Depression |
| 126086091 | 12608609 | 3 | Fluid retention |
| 126086091 | 12608609 | 4 | Anxiety |
| 126086091 | 12608609 | 5 | Supplementation therapy |
| 126086091 | 12608609 | 6 | Supplementation therapy |
| 126086091 | 12608609 | 7 | Supplementation therapy |
| 126086091 | 12608609 | 8 | Supplementation therapy |
| 126086091 | 12608609 | 9 | Supplementation therapy |
| 126086091 | 12608609 | 10 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126086091 | 12608609 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126086091 | 12608609 | Abnormal dreams | |
| 126086091 | 12608609 | Asthenia | |
| 126086091 | 12608609 | Crying | |
| 126086091 | 12608609 | Diarrhoea | |
| 126086091 | 12608609 | Disturbance in attention | |
| 126086091 | 12608609 | Dizziness | |
| 126086091 | 12608609 | Eye movement disorder | |
| 126086091 | 12608609 | Fatigue | |
| 126086091 | 12608609 | Fear | |
| 126086091 | 12608609 | Feeling cold | |
| 126086091 | 12608609 | Hot flush | |
| 126086091 | 12608609 | Hypoaesthesia | |
| 126086091 | 12608609 | Hypothyroidism | |
| 126086091 | 12608609 | Insomnia | |
| 126086091 | 12608609 | Lethargy | |
| 126086091 | 12608609 | Memory impairment | |
| 126086091 | 12608609 | Nausea | |
| 126086091 | 12608609 | Nervousness | |
| 126086091 | 12608609 | Pain | |
| 126086091 | 12608609 | Pain in extremity | |
| 126086091 | 12608609 | Paraesthesia | |
| 126086091 | 12608609 | Peripheral coldness | |
| 126086091 | 12608609 | Sinusitis | |
| 126086091 | 12608609 | Skin discolouration | |
| 126086091 | 12608609 | Vision blurred | |
| 126086091 | 12608609 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126086091 | 12608609 | 1 | 2011 | 201606 | 0 | |
| 126086091 | 12608609 | 2 | 2016 | 0 | ||
| 126086091 | 12608609 | 5 | 2010 | 0 | ||
| 126086091 | 12608609 | 7 | 2010 | 0 | ||
| 126086091 | 12608609 | 8 | 2010 | 0 | ||
| 126086091 | 12608609 | 9 | 2015 | 0 | ||
| 126086091 | 12608609 | 10 | 2015 | 0 |